tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ME Stock Latest News

Petros Pharmaceuticals launches U.S. distribution of STENDRA
The FlyPetros Pharmaceuticals launches U.S. distribution of STENDRA
6d ago
ME
PTPI
23andMe’s Lemonaid Health collabs with Petros Pharmaceuticals
PremiumThe Fly
23andMe’s Lemonaid Health collabs with Petros Pharmaceuticals
6d ago
ME
PTPI
23andMe to Report Q4 and Full Year FY2024 Financial Results
PremiumPress Releases
23andMe to Report Q4 and Full Year FY2024 Financial Results
11d ago
ME
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
26d ago
ME
Petros Pharmaceuticals expands online distribution for prescription STENDRA
PremiumThe Fly
Petros Pharmaceuticals expands online distribution for prescription STENDRA
27d ago
ME
PTPI
Petros Pharmaceuticals expands online distribution for prescription STENDRA
PremiumThe FlyPetros Pharmaceuticals expands online distribution for prescription STENDRA
27d ago
ME
PTPI
M&A News: 23andMe (NASDAQ:ME) Soars on CEO’s Take-Private Intention
PremiumMarket News
M&A News: 23andMe (NASDAQ:ME) Soars on CEO’s Take-Private Intention
1M ago
ME
23andMe Forms Special Committee for Strategic Governance
PremiumCompany Announcements
23andMe Forms Special Committee for Strategic Governance
1M ago
8K
ME
23andMe announces CEO’s intention to pursue potential take-private
PremiumThe Fly
23andMe announces CEO’s intention to pursue potential take-private
1M ago
ME
23andMe price target lowered to 47c from 85c at Citi
PremiumThe Fly
23andMe price target lowered to 47c from 85c at Citi
1M ago
ME
WW appoints new executive leaders
PremiumThe Fly
WW appoints new executive leaders
1M ago
ME
WW
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
PremiumPress Releases
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
1M ago
ME
23andMe CAO Kathy Hibbs Retires, Guy Chayoun Steps In
PremiumCompany Announcements23andMe CAO Kathy Hibbs Retires, Guy Chayoun Steps In
2M ago
8K
ME
23andMe initiates Phase 1 trial for 23ME-01473
PremiumThe Fly
23andMe initiates Phase 1 trial for 23ME-01473
2M ago
ME
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
PremiumPress Releases
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
2M ago
ME
23andMe launches feature connecting customers to historic individuals
PremiumThe Fly
23andMe launches feature connecting customers to historic individuals
2M ago
ME
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago
PremiumPress Releases
23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago
2M ago
ME
23andMe launches new genetic report on forms of cancer
PremiumThe Fly
23andMe launches new genetic report on forms of cancer
3M ago
ME
23andMe Launches New Genetic Reports on Common Forms of Cancer
PremiumPress Releases
23andMe Launches New Genetic Reports on Common Forms of Cancer
3M ago
ME
23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
PremiumPress Releases23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
3M ago
ME
23andMe price target lowered to 85c from 90c at Citi
PremiumThe Fly
23andMe price target lowered to 85c from 90c at Citi
3M ago
ME
23andMe reduces FY24 revenue view to $215M-$220M, consensus $245.45M
PremiumThe Fly
23andMe reduces FY24 revenue view to $215M-$220M, consensus $245.45M
3M ago
ME

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >